Compare iShares MSCI Singapore ETF (EWS) vs Procter & Gamble Co (PG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Singapore ETF vs Procter & Gamble Co — how do they compare? iShares MSCI Singapore ETF trades at $33.92, while Procter & Gamble Co trades at $145.2 (market cap $340.39B). The key difference: Procter & Gamble Co pays a 2.97% dividend while iShares MSCI Singapore ETF pays none, and iShares MSCI Singapore ETF is trading nearer its 52-week high, Procter & Gamble Co nearer its low. Which is the better fit depends on your goals.
| EWS | PG | |
|---|---|---|
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $33.92 | $167.18 |
52-Week Low | $26.71 | $138.10 |
Market Cap | — | $340.39B |
Volume | — | 6,423,436 |
Enterprise Value | — | $366.23B |
Dividend Yield | — | 2.97% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWS, the iShares MSCI Singapore ETF, trades at $33.25, up 2.15% today, with a bullish technical signal from moving averages and oscillators. The ETF offers exposure to Singapore's equity market, highlighted by a 3.97% dividend yield and institutional interest, such as Amundi's 4.8% stake increase in Q2 2026. Recent news emphasizes Singapore's economic resilience and AI-driven growth opportunities.
The outlook for EWS is positive due to Singapore's stable economy and sector reforms, but risks include concentrated holdings in financials and regional volatility. Investors may find value in its diversification benefits and dividend consistency, though monitoring economic shifts in Asia is essential for sustained performance.
Procter & Gamble (PG) trades at $146.38, up 0.42% today, with a bearish technical signal but strong fundamentals. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $1.90. Revenue reached $84.28B in 2025, with a net income margin of 18.44% and robust cash flow from operations of $17.82B. Analyst consensus is bullish with a $161.20 price target, though valuation multiples like P/E of 22.12 and P/S of 4.08 are at premiums to peers.
The outlook for PG is positive due to steady earnings growth and dividend reliability, but risks include premium valuation concerns and soft demand headwinds. Investors may find opportunity in its defensive qualities amid market volatility, though near-term upside could be limited by technical resistance and modest revenue growth projections.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI Singapore ETF
EWS tracks the MSCI Singapore 25/50 Index, providing targeted exposure to large and mid-cap companies in Singapore. It is heavily weighted toward the financial, industrial, and real estate sectors, serving as a liquid tool for accessing Singapore's stable, dividend-oriented developed economy.
Read more on EWS →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
